"With a robust library of family histories and linked diseases at our finger tips, we aim to define the genetic makeup of spinal disorders in an effort to develop diagnostic and prognostic tests that can enable the medical community to provide more personalized spine care."

— Kenneth Ward, MD, Axial Biotech's CSO and chairman discussing a collaboration with the University of Utah that allows Axial access to the university's genetic resources including the Utah Population Database (UPDB), "Axial to use Utah database for scoliosis prognostic test."